Roche Pharmaceuticals division revenue share by therapeutic area 2023 | Statista

This statistic shows the revenue distribution of Roche's Pharmaceuticals division from 2013 to 2023, by therapeutic area. In 2023, oncology was the leading therapeutic area of the Pharmaceuticals division generating some 43 percent of the division's total revenues. Although leading, oncology in general saw a significant decline over the last eight years, losing over 20 percent of the division's revenues.

Revenue distribution of Roche's Pharmaceuticals division from 2013 to 2023, by therapeutic area

Characteristic	Oncology	Neuroscience	Immunology	Haemophilia A	Ophthalmology	Infectious diseases	Other
2013	62%	2%	13%	-	5%	9%	9%
2014	62%	2%	14%	-	5%	9%	8%
2015	63%	2%	17%	-	4%	5%	9%
2016	64%	2%	18%	-	4%	5%	7%
2017	62.5%	3.7%	18.5%	-	3.4%	3.3%	8.6%
2018	59.6%	6.8%	18.6%	0.5%	3.8%	2.5%	8.2%
2019	56.8%	9%	17.5%	2.8%	3.8%	2.2%	7.9%
2020	52.4%	11.1%	18.5%	4.9%	3.2%	1.9%	8%
2021	45.4%	13.9%	18.6%	6.7%	3%	4.9%	7.5%
2022	43.9%	17.2%	15.8%	8.4%	3.6%	4.7%	6.4%
2023	42.8%	18.9%	14%	9.3%	6.4%	2.4%	6.2%

Loading statistic...

Download

Source

Show detailed source information?

Register for free

Already a member?

Source

Use Ask Statista Research Service

Release date

February 2024

More information

Region

Worldwide

Survey time period

2013 to 2023

Citation formats

Other statistics on the topic
Roche

Number of active specialty physicians in the U.S. in 2024, by field of specialty

Health Professionals & Hospitals

Number of specialty physicians in the U.S. 2024, by field of specialty

Deaths by cancer in the U.S. from 1950 to 2022 (per 100,000 population)

State of Health

Deaths by cancer in the U.S. 1950-2022

Number of U.S. physicians in oncology specialties in 2016

Health Professionals & Hospitals

Number of oncology specialty physicians in the U.S. 2016

Forecast of leading pharmaceutical companies based on global oncology sales in 2030 (in billion U.S. dollars)

Pharmaceutical Products & Market

Global top 5 companies by forecasted oncology sales 2030

Access all statistics starting from $2,388 USD yearly ^*

* For commercial use only

For single users

$0 USD

Always free

Access limited to Free Statistics. Premium Statistics are not included.

Free Statistics

Based on your interests

For single users

$199 USD

per month, billed annually ¹

Free Statistics
Premium Statistics

For teams of up to 5 people

$959 USD

per month, billed annually ¹

Free + Premium Statistics
Reports
Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Oncology "

The most important statistics

The most important statistics

The most important statistics

The most important statistics

The most important statistics

The most important statistics

The most important statistics

The most important statistics

Other statistics that may interest you Oncology

Cancer facts

5

Oncology market

6

Companies

7

Cancer drugs

5

Research and development

6

Immuno-oncology

5

Treatment types

5

Physicians and patients

8

Further related statistics

20

Further Content: You might find this interesting as well

Statistics

Topics

Global pharmaceutical industry

Johnson & Johnson

Cancer in the U.S.

Access all statistics starting from $2,388 USD yearly ^*

* For commercial use only

For single users

$0 USD

Always free

Access limited to Free Statistics. Premium Statistics are not included.

Free Statistics

Based on your interests

For single users

$199 USD

per month, billed annually ¹

Free Statistics
Premium Statistics

For teams of up to 5 people

$959 USD

per month, billed annually ¹

Free + Premium Statistics
Reports
Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Learn more about how Statista can support your business.